Diabetes research: At this year's congress of the European Association for the Study of Diabetes (EASD), Helmholtz Munich scientists received several awards for pioneering ideas and ways to fight the disease.
Researchers at Helmholtz Munich are working toward a world without diabetes. They are not doing so alone, but with a network of organizations, hospitals, and pharmaceutical companies. Their goal is to use experts’ knowledge to create something new:…
At Helmholtz Munich, scientists are working to ensure that no child will have to suffer from the autoimmune disease type 1 diabetes in the future.
A team of researchers from Helmholtz Munich, the German Center for Diabetes Research (DZD) and Novo Nordisk have developed a new hormone combination for the future treatment of type 2 diabetes. The scientists have combined the blood sugar-reducing…
Prof. Dr. Anette-Gabriele Ziegler, Director of the Helmholtz Munich Institute of Diabetes Research (IDF) receives this year’s EASD–Novo Nordisk Foundation Diabetes Prize for Excellence. The prize is awarded to honor outstanding contributions to the…
Helmholtz Munich scientist Stephanie Kullmann is awarded this year's Ferdinand Bertram Award of the German Diabetes Society (DDG). With this award, the DDG honors her research on the role of central nervous processes in the prevention and treatment…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player or Twitter feeds. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:
